These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21507255)

  • 1. Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer.
    Xu XS; Wang L; Abrams J; Wang G
    J Hematol Oncol; 2011 Apr; 4():17. PubMed ID: 21507255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression.
    Chen Z; Yang J; Wang G; Song B; Li J; Xu Z
    Cancer Res; 2007 May; 67(10):4578-85. PubMed ID: 17510383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
    Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
    PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer.
    Wang H; Huang Y; Shi J; Zhi Y; Yuan F; Yu J; Chen Z; Yang J
    Cancer Lett; 2019 Mar; 444():136-146. PubMed ID: 30579971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN; Kim NH; Lee W; Seo DW; Kim YK
    Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription.
    Liu Y; Wang X; Li W; Xu Y; Zhuo Y; Li M; He Y; Wang X; Guo Q; Zhao L; Qiang L
    Oncogene; 2020 Nov; 39(45):6893-6905. PubMed ID: 32978517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC3 Is Required for XPC Recruitment and Nucleotide Excision Repair of DNA Damage Induced by UV Irradiation.
    Nishimoto K; Niida H; Uchida C; Ohhata T; Kitagawa K; Motegi A; Suda T; Kitagawa M
    Mol Cancer Res; 2020 Sep; 18(9):1367-1378. PubMed ID: 32527949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.
    Vallo S; Xi W; Hudak L; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
    Anticancer Drugs; 2011 Nov; 22(10):1002-9. PubMed ID: 21822119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntaxin 1A Gene Is Negatively Regulated in a Cell/Tissue Specific Manner by YY1 Transcription Factor, Which Binds to the -183 to -137 Promoter Region Together with Gene Silencing Factors Including Histone Deacetylase.
    Nakayama T; Fukutomi T; Terao Y; Akagawa K
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33498722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer.
    Qiu J; Wang X; Meng X; Zheng Y; Li G; Ma J; Ye G; Li Y; Li J
    PLoS One; 2014; 9(12):e115224. PubMed ID: 25535740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide excision repair factor XPC enhances DNA damage-induced apoptosis by downregulating the antiapoptotic short isoform of caspase-2.
    Wang QE; Han C; Zhang B; Sabapathy K; Wani AA
    Cancer Res; 2012 Feb; 72(3):666-75. PubMed ID: 22174370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
    Wang G; Dombkowski A; Chuang L; Xu XX
    Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas.
    Rezvani HR; Kim AL; Rossignol R; Ali N; Daly M; Mahfouf W; Bellance N; Taïeb A; de Verneuil H; Mazurier F; Bickers DR
    J Clin Invest; 2011 Jan; 121(1):195-211. PubMed ID: 21123941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.
    Yang J; Xu Z; Li J; Zhang R; Zhang G; Ji H; Song B; Chen Z
    J Urol; 2010 Jul; 184(1):336-43. PubMed ID: 20488473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
    García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylases regulate gonadotropin-releasing hormone I gene expression via modulating Otx2-driven transcriptional activity.
    Gan L; Ni PY; Ge Y; Xiao YF; Sun CY; Deng L; Zhang W; Wu SS; Liu Y; Jiang W; Xin HB
    PLoS One; 2012; 7(6):e39770. PubMed ID: 22761896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.